tiprankstipranks
Tryp Therapeutics Inc (TSE:TRYP)
CNQX:TRYP

Tryp Therapeutics Inc (TRYP) Financial Statements

13 Followers

Tryp Therapeutics Inc Financial Overview

Tryp Therapeutics Inc's market cap is currently ―. The company's EPS TTM is C$-0.049; its P/E ratio is -0.50; Tryp Therapeutics Inc is scheduled to report earnings on April 26, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -1.16MC$ -1.56MC$ -783.84KC$ -1.29MC$ -1.64M
EBITDAC$ -1.16MC$ -1.56MC$ -783.84KC$ -1.29M-
Net Income Common StockholdersC$ -1.16MC$ -1.69MC$ -655.80KC$ -1.29MC$ -1.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 2.06MC$ 359.19KC$ 1.29MC$ 43.84KC$ 833.92K
Total AssetsC$ 2.35MC$ 653.05KC$ 1.62MC$ 501.07KC$ 1.26M
Total DebtC$ 5.01MC$ 2.10MC$ 1.23MC$ 0.00C$ 0.00
Net DebtC$ 2.95MC$ 1.74MC$ -65.37KC$ -43.84KC$ -833.92K
Total LiabilitiesC$ 7.25MC$ 4.41MC$ 3.63MC$ 1.99MC$ 1.57M
Stockholders EquityC$ -4.89MC$ -3.76MC$ -2.01MC$ -1.49MC$ -305.27K
Cash Flow-
Free Cash FlowC$ -968.99KC$ -1.12MC$ -2.51MC$ -789.41KC$ -970.60K
Operating Cash FlowC$ -968.99KC$ -1.12MC$ -2.50MC$ -789.41KC$ -970.60K
Investing Cash Flow--C$ -8.17K--
Financing Cash FlowC$ 2.67MC$ 183.08KC$ 1.96M--
Currency in CAD

Tryp Therapeutics Inc Earnings and Revenue History

Tryp Therapeutics Inc Debt to Assets

Tryp Therapeutics Inc Cash Flow

Tryp Therapeutics Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis